|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Healthy | |||||
| 2 | Interventions listed in this trial | ||||
| Atropine | |||||
| Propranolol | |||||
| 3 | More general drug interventions related to this trial | ||||
| Adjuvants, Anesthesia | |||||
| Adrenergic Agents | |||||
| Adrenergic Antagonists | |||||
| Adrenergic beta-Antagonists | |||||
| Anti-Arrhythmia Agents | |||||
| Anti-Asthmatic Agents | |||||
| Antihypertensive Agents | |||||
| Autonomic Agents | |||||
| Bronchodilator Agents | |||||
| Cardiovascular Agents | |||||
| Central Nervous System Agents | |||||
| Cholinergic Agents | |||||
| Cholinergic Antagonists | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Muscarinic Antagonists | |||||
| Mydriatics | |||||
| Neurotransmitter Agents | |||||
| Parasympatholytics | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Respiratory System Agents | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||